Literature DB >> 16413848

Combined oral contraceptive use among women with hypertension: a systematic review.

Kathryn M Curtis1, Anshu P Mohllajee, Summer L Martins, Herbert B Peterson.   

Abstract

Women with hypertension are at increased risk for cardiovascular events. Combined oral contraceptive (COC) use, even among low-dose users, has been associated with a small excess risk for cardiovascular events among healthy women. In this systematic review, we examined cardiovascular risks among COC users with hypertension. After searching MEDLINE for all articles published from 1966 through February 2005 relevant to COC use, hypertension and cardiovascular disease, we identified 25 articles for this review. Overall, these studies showed that hypertensive COC users were at higher risk for stroke and acute myocardial infarction (AMI) than hypertensive non-COC users, but that they were not at higher risk for venous thromboembolism (VTE). Women who did not have their blood pressure measured before initiating COC use were at higher risk for ischemic stroke and AMI, but not for hemorrhagic stroke or VTE, than COC users who did not have their blood pressure measured.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16413848     DOI: 10.1016/j.contraception.2005.08.005

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  9 in total

Review 1.  Medical Eligibility for Contraception in Women at Increased Risk.

Authors:  Thomas Römer
Journal:  Dtsch Arztebl Int       Date:  2019-11-08       Impact factor: 5.594

2.  Initiation of oral contraceptives and changes in blood pressure and body mass index in healthy adolescents.

Authors:  Elyse Olshen Kharbanda; Emily D Parker; Alan R Sinaiko; Matthew F Daley; Karen L Margolis; Mary Becker; Nancy E Sherwood; David J Magid; Patrick J O'Connor
Journal:  J Pediatr       Date:  2014-09-01       Impact factor: 4.406

3.  Safety of contraceptive use among women with congenital heart disease: A systematic review.

Authors:  Ginnie Abarbanell; Naomi K Tepper; Sherry L Farr
Journal:  Congenit Heart Dis       Date:  2019-01-25       Impact factor: 2.007

Review 4.  Stroke in women: risk and prevention throughout the lifespan.

Authors:  Cheryl D Bushnell
Journal:  Neurol Clin       Date:  2008-11       Impact factor: 3.806

5.  Oral Contraceptive Use and Increased Risk of Stroke: A Dose-Response Meta-Analysis of Observational Studies.

Authors:  Feng Li; Lin Zhu; Jie Zhang; Hongye He; Yueqi Qin; Yuan Cheng; Zongyi Xie
Journal:  Front Neurol       Date:  2019-09-23       Impact factor: 4.003

6.  Bloodletting has no effect on the blood pressure abnormalities of hyperandrogenic women taking oral contraceptives in a randomized clinical trial.

Authors:  Manuel Luque-Ramírez; Andrés E Ortiz-Flores; Lía Nattero-Chávez; M Ángeles Martínez-García; María Insenser; Francisco Álvarez-Blasco; Elena Fernández-Durán; Alejandra Quintero-Tobar; Sara de Lope Quiñones; Héctor F Escobar-Morreale
Journal:  Sci Rep       Date:  2021-11-11       Impact factor: 4.379

7.  Demographic, socioeconomic, and biological correlates of hypertension in an adult population: evidence from the Bangladesh demographic and health survey 2017-18.

Authors:  Afrin Iqbal; Karar Zunaid Ahsan; Kanta Jamil; M Moinuddin Haider; Shusmita Hossain Khan; Nitai Chakraborty; Peter Kim Streatfield
Journal:  BMC Public Health       Date:  2021-06-26       Impact factor: 3.295

8.  Use of simulated patients to evaluate combined oral contraceptive dispensing practices of community pharmacists.

Authors:  Paulo Roque Obreli-Neto; Leonardo Régis Leira Pereira; Camilo Molino Guidoni; André de Oliveira Baldoni; Srecko Marusic; Divaldo Pereira de Lyra-Júnior; Kelsen Luis de Almeida; Ana Claudia Montolezi Pazete; Janaina Dutra do Nascimento; Mitja Kos; Edmarlon Girotto; Roberto Kenji Nakamura Cuman
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

Review 9.  Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits.

Authors:  Anderson Sanches de Melo; Rosana Maria Dos Reis; Rui Alberto Ferriani; Carolina Sales Vieira
Journal:  Open Access J Contracept       Date:  2017-02-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.